Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?
about
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer.An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy.Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype.
P2860
Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Molecular analysis of local re ...... ime factors make a difference?
@ast
Molecular analysis of local re ...... ime factors make a difference?
@en
type
label
Molecular analysis of local re ...... ime factors make a difference?
@ast
Molecular analysis of local re ...... ime factors make a difference?
@en
prefLabel
Molecular analysis of local re ...... ime factors make a difference?
@ast
Molecular analysis of local re ...... ime factors make a difference?
@en
P2093
P2860
P356
P1476
Molecular analysis of local re ...... ime factors make a difference?
@en
P2093
A Giatromanolaki
E Sivridis
G Galazios
M I Koukourakis
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600755
P407
P577
2003-03-01T00:00:00Z